Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Eur J Neurol. 2017 Mar 20;24(5):713–718. doi: 10.1111/ene.13276

Table 2.

The adjusted odds ratios (OR) of having benign or malignant skin tumors by selected demographics and clinical factors in patients with DM

Variables OR (95% CI)a P-value
Benign Tumors Age at enrollment 0.99 (0.95–1.05) 0.94
Age at DM diagnosis 1.02 (0.98–1.07) 0.34
Female vs. male 0.42 (0.19–0.94) 0.03
DM1 vs. DM2 1.62 (0.57–4.63) 0.37
Malignant Tumors Age at enrollment 1.10 (1.05–1.16) <0.001
Age at DM diagnosis 0.99 (0.96–1.03) 0.80
Female vs. male 2.27 (1.02–5.05) 0.04
DM1 vs. DM2 3.42 (1.27–9.26) 0.02
a

Odds ratio and 95% confidence interval; the model included age at enrollment, age at DM diagnosis, gender, and DM subtype (DM1 or DM2).